BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7688309)

  • 1. Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody.
    Lesley J; Kincade PW; Hyman R
    Eur J Immunol; 1993 Aug; 23(8):1902-9. PubMed ID: 7688309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells.
    Lesley J; Hyman R
    Eur J Immunol; 1992 Oct; 22(10):2719-23. PubMed ID: 1382996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding.
    English NM; Lesley JF; Hyman R
    Cancer Res; 1998 Aug; 58(16):3736-42. PubMed ID: 9721887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction.
    Bourguignon LY; Lokeshwar VB; Chen X; Kerrick WG
    J Immunol; 1993 Dec; 151(12):6634-44. PubMed ID: 7505012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CD44 cytoplasmic domain in hyaluronan binding.
    Perschl A; Lesley J; English N; Trowbridge I; Hyman R
    Eur J Immunol; 1995 Feb; 25(2):495-501. PubMed ID: 7533087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of functional CD44 hyaluronan receptor on human NMYC-amplified neuroblastoma cells.
    Gross N; Balmas K; Brognara CB
    Cancer Res; 1997 Apr; 57(7):1387-93. PubMed ID: 9102228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.
    Liao HX; Levesque MC; Patton K; Bergamo B; Jones D; Moody MA; Telen MJ; Haynes BF
    J Immunol; 1993 Dec; 151(11):6490-9. PubMed ID: 7504022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 expression on activated B cells. Differential capacity for CD44-dependent binding to hyaluronic acid.
    Hathcock KS; Hirano H; Murakami S; Hodes RJ
    J Immunol; 1993 Dec; 151(12):6712-22. PubMed ID: 7505013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells.
    Galluzzo E; Albi N; Fiorucci S; Merigiola C; Ruggeri L; Tosti A; Grossi CE; Velardi A
    Eur J Immunol; 1995 Oct; 25(10):2932-9. PubMed ID: 7589094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras-transformed cells express both CD44 and RHAMM hyaluronan receptors: only RHAMM is essential for hyaluronan-promoted locomotion.
    Turley EA; Austen L; Moore D; Hoare K
    Exp Cell Res; 1993 Aug; 207(2):277-82. PubMed ID: 7688314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation.
    Denning SM; Le PT; Singer KH; Haynes BF
    J Immunol; 1990 Jan; 144(1):7-15. PubMed ID: 1967267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible binding of human lymphocytes to hyaluronate via CD44 does not require cytoskeleton association but does require new protein synthesis.
    Murakami S; Shimabukuro Y; Miki Y; Saho T; Hino E; Kasai D; Nozaki T; Kusumoto Y; Okada H
    J Immunol; 1994 Jan; 152(2):467-77. PubMed ID: 7506725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
    Fan Z; Masui H; Altas I; Mendelsohn J
    Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells.
    Galandrini R; Galluzzo E; Albi N; Grossi CE; Velardi A
    J Immunol; 1994 Jul; 153(1):21-31. PubMed ID: 7515923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells.
    Asplund T; Heldin P
    Cancer Res; 1994 Aug; 54(16):4516-23. PubMed ID: 7519123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody.
    Lesley J; He Q; Miyake K; Hamann A; Hyman R; Kincade PW
    J Exp Med; 1992 Jan; 175(1):257-66. PubMed ID: 1730918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of hyaluronan receptor (CD44) function in vivo in a murine model of rheumatoid arthritis.
    Mikecz K; Dennis K; Shi M; Kim JH
    Arthritis Rheum; 1999 Apr; 42(4):659-68. PubMed ID: 10211879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
    Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE
    J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent.
    Zahalka MA; Okon E; Gosslar U; Holzmann B; Naor D
    J Immunol; 1995 May; 154(10):5345-55. PubMed ID: 7537306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells.
    Hirsch R; Gress RE; Pluznik DH; Eckhaus M; Bluestone JA
    J Immunol; 1989 Feb; 142(3):737-43. PubMed ID: 2521507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.